CELYAD ONCOLOGY
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CYADY and buy or sell other stocks, ETFs, and their options commission-free!About CYADY
Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through the following segments: Cardiology and Immuno-Oncology.
CEOMatthew R. Kane, MBA
CEOMatthew R. Kane, MBA
Employees15
Employees15
HeadquartersMont-Saint-Guibert, Walloon Region
HeadquartersMont-Saint-Guibert, Walloon Region
Founded2007
Founded2007
Employees15
Employees15
CYADY Key Statistics
Market cap24.86M
Market cap24.86M
Price-Earnings ratio-0.43
Price-Earnings ratio-0.43
Dividend yield—
Dividend yield—
Average volume6.73K
Average volume6.73K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.07
52 Week high$3.07
52 Week low$0.15
52 Week low$0.15
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.